DICE Therapeutics Inc (DICE) Forecast, Price Target & Analyst Ratings

Q: What do analysts expect the price target to be for DICE Therapeutics Inc (DICE)?

14 analysts have analysed DICE and the average price target is 50.36 USD. This implies a price increase of 5.91% is expected in the next year compared to the current price of 47.55.

NASDAQ:DICE • US23345J1043

47.55 USD

+0.03 (+0.06%)

At close: Aug 8, 2023

47.59 USD

+0.04 (+0.08%)

After Hours: 8/8/2023, 9:37:47 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DICE Therapeutics Inc (DICE).

Consensus Price Target

Price Target

$50.36

+ 5.91% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: N/A
Period: Q2 / 2023
EPS Estimate: -$0.66
Revenue Estimate

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

52.86%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$50.36

Upside

+ 5.91%

From current price of $47.55 to mean target of $50.36, Based on 14 analyst forecasts

Low

$48.48

Median

$48.96

High

$61.95

Price Target Revisions

1 Month

0.31%

3 Months

-20.20%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for DICE. The average price target is 50.36 USD. This implies a price increase of 5.91% is expected in the next year compared to the current price of 47.55.

The average price target has been revised downward by 20.2% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

52.86%

DICE was analyzed by 14 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about DICE.

In the last month the buy percentage fell by 17 points. So the trust of analysts is decreasing.

DICE was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2023-08-09	HC Wainwright & Co.	Reiterate	Neutral
2023-06-26	Needham	Downgrade	Buy -> Hold
2023-06-21	Canaccord Genuity	Downgrade	Buy -> Hold
2023-06-21	HC Wainwright & Co.	Downgrade	Buy -> Neutral
2023-06-20	Cantor Fitzgerald	Downgrade	Overweight -> Neutral
2023-06-20	Wells Fargo	Maintains	Equal-Weight
2023-06-20	Canaccord Genuity	Downgrade	Buy -> Hold
2023-05-24	Wells Fargo	Initiate	Equal-Weight
2023-05-22	Canaccord Genuity	Initiate	Buy
2023-05-12	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-03-31	Needham	Reiterate	Buy
2023-03-20	HC Wainwright & Co.	Reiterate	Buy
2023-03-16	HC Wainwright & Co.	Reiterate	Buy
2023-03-08	HC Wainwright & Co.	Reiterate	Buy
2023-03-01	Cowen & Co.	Initiate	Outperform
2022-11-15	Guggenheim	Initiate	Buy
2022-10-11	SVB Leerink	Maintains	Outperform
2022-10-11	HC Wainwright & Co.	Maintains	Buy
2022-09-14	Cantor Fitzgerald	Initiate	Overweight
2022-09-07	Stifel	Initiate	Buy
2022-07-18	HC Wainwright & Co.	Initiate	Buy
2021-10-11	B of A Securities	Initiate	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: N/A
Period: Q2 / 2023
EPS Estimate: -$0.66
Revenue Estimate
Revenue Q2Q: N/A
EPS Q2Q: -14.12%
Number of Analysts: 11

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

0.00%

EPS (3 Months)

1.58%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	5.775M	863K -85.06%	1.125M 30.36%	-100.00%			1.894M	2.21M 16.68%	34.918M 1,480.00%	197.94M 466.87%	441.13M 122.86%	772.18M 75.05%
EBITDA YoY % growth	-12.041M	-23.024M -91.21%	-46.942M -103.88%	-84.67M -86.18%	-135.752M -55.33%	-200.95M -48.03%	N/A	N/A	N/A	N/A	N/A	N/A
EBIT YoY % growth	-12.747M	-23.721M -86.09%	-47.603M -100.68%	-85.665M -85.33%	-136.802M -55.07%	-175.522M -28.30%	-249.237M -42.00%	-257.264M -3.22%	-303.817M -18.10%	-302.915M 0.30%	-171.233M 43.47%	83.921M 149.01%
Operating Margin	-220.73%	-2,748.67%	-4,231.38%	N/A	N/A	N/A	-13,159.29%	-11,640.92%	-870.09%	-153.03%	-38.82%	10.87%
EPS YoY % growth	N/A	N/A	N/A	-2.11 12.46%	-2.62 -22.45%	-3.43 -31.06%	-4.05 -18.07%	-4.80 -18.48%	-4.17 13.16%	-1.64 60.76%	1.91 216.51%	6.10 220.05%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q2 / 23	Q3 / 23	Q4 / 23
EPS Q2Q % growth	-0.66 -14.12%	-0.70 -27.55%	-0.69 -34.44%
Revenue Q2Q % growth
EBITDA Q2Q % growth	N/A	N/A	N/A
EBIT Q2Q % growth	-34.057M -56.63%	-36.04M -70.25%	-34.51M -30.47%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

-23.74%

EPS Next 5 Year

-14.28%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

N/A

Revenue Next 5 Year

N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DICE Therapeutics Inc / DICE Forecast FAQ

What do analysts expect the price target to be for DICE Therapeutics Inc (DICE)?

14 analysts have analysed DICE and the average price target is 50.36 USD. This implies a price increase of 5.91% is expected in the next year compared to the current price of 47.55.

What are the consensus estimates for DICE stock next earnings?

The consensus EPS estimate for the next earnings of DICE Therapeutics Inc (DICE) is -0.66 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for DICE stock?

The number of analysts covering DICE Therapeutics Inc (DICE) is 14.

Analyst forecast overview

Forecast Snapshot